MoneyWorks4Me

Jubilant Life repays Rs 900 cr for outstanding FCCBs

24 May 2011 Evaluate

Pharmaceutical firm Jubilant Life Sciences has repaid nearly Rs 900 crore ($202 million) for redemption of outstanding overseas bonds. After the repayment of its last FCCBs amounting to $202 million, there are no major debt repayments due for the next 3 years. The company has repaid all the outstanding FCCBs on time in line with terms and conditions of the FCCB instruments.

crackcrack

Jubilant Pharmova Share Price

879.15 5.55 (0.64%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: